Skip header and navigation

2 records – page 1 of 1.

Prevention of viral hepatitis in the Nordic countries and Germany.

https://arctichealth.org/en/permalink/ahliterature9142
Source
Scand J Infect Dis. 2005;37(8):549-60
Publication Type
Article
Date
2005
Author
David Fitzsimons
Guido François
Katharina Alpers
Doris Radun
Johannes Hallauer
Wolfgang Jilg
Wolfram Gerlich
Lars Rombo
Hans Blystad
Hanne Nøkleby
Pierre van Damme
Author Affiliation
World Health Organization, Geneva, Switzerland.
Source
Scand J Infect Dis. 2005;37(8):549-60
Date
2005
Language
English
Publication Type
Article
Keywords
Adolescent
Adult
Child
Disease Outbreaks
Female
Germany - epidemiology
Hepatitis, Viral, Human - epidemiology - immunology - prevention & control
Homosexuality, Male
Humans
Immunization Programs - organization & administration
Male
Population Surveillance - methods
Research Support, Non-U.S. Gov't
Scandinavia - epidemiology
Substance Abuse, Intravenous
Abstract
The Viral Hepatitis Prevention Board (VHPB) convened a meeting of international experts from the public and private sectors in the Nordic countries and Germany, in order to review the epidemiological situation, the surveillance systems for infectious diseases, the immunization programmes and policy, and the monitoring of adverse events after hepatitis vaccination in those countries, to evaluate prevention and control measures, and to identify the issues that arose and the lessons learnt. Considerable progress has been made in the past decades in the prevention and control of viral hepatitis in the respective countries. Vaccination programmes have been set up, blood products' safety has significantly been improved, and outbreak investigations remain the basis for the implementation of control measures. However, additional work remains to be done. Awareness of viral hepatitis among the public and professionals should further be raised, and more political support is needed regarding the value of prevention efforts and vaccination programmes.
PubMed ID
16099768 View in PubMed
Less detail

Seroprevalence of hepatitis B virus, hepatitis C virus and GB virus-C infections in Siberia.

https://arctichealth.org/en/permalink/ahliterature56708
Source
Epidemiol Infect. 1999 Feb;122(1):139-43
Publication Type
Article
Date
Feb-1999
Author
K. Ohba
M. Mizokami
T. Kato
R. Ueda
V. Gurtsenvitch
N. Senyuta
A. Syrtsev
K. Zoya
M. Yamashita
M. Hayami
Author Affiliation
Second Department of Medicine, Nagoya City University Medical School, Kawasumi, Mizuho, Japan.
Source
Epidemiol Infect. 1999 Feb;122(1):139-43
Date
Feb-1999
Language
English
Publication Type
Article
Keywords
Adolescent
Adult
Age Distribution
Aged
Aged, 80 and over
Endemic Diseases - prevention & control - statistics & numerical data
Female
Flaviviridae
Hepatitis B - epidemiology - immunology - prevention & control - virology
Hepatitis C - epidemiology - immunology - prevention & control - virology
Hepatitis, Viral, Human - epidemiology - immunology - prevention & control - virology
Humans
Male
Middle Aged
Population Surveillance
Research Support, Non-U.S. Gov't
Reverse Transcriptase Polymerase Chain Reaction
Seroepidemiologic Studies
Serotyping
Siberia - epidemiology
Vaccination
Abstract
We studied the seroprevalence of hepatitis B virus (HBV), hepatitis C virus (HCV) and GB virus-C (GBV-C) infections in 348 Siberian natives who lived in the Kamchatka Peninsula of Russia. Of 348 samples studied, the seroprevalence of HBsAg and anti-HBs were 11.8% (41 of 348 samples) and 35.9% (125 of 348 samples), respectively. The prevalence of HCV infection was 1.4% (5 of 348 samples), and that of GBV-C RNA, using RT-PCR methods, was 7.5% (26 of 348 samples). In Siberia, the prevalences of HBV and GBV-C infections were about tenfold higher than those in Japan. The prevalence of HBsAg in subjects under 50 years of age was significantly higher than that in those over 50 years old (P
PubMed ID
10098797 View in PubMed
Less detail